Literature DB >> 10744091

Neurological manifestations of dengue infection.

T Solomon1, N M Dung, D W Vaughn, R Kneen, L T Thao, B Raengsakulrach, H T Loan, N P Day, J Farrar, K S Myint, M J Warrell, W S James, A Nisalak, N J White.   

Abstract

BACKGROUND: Severe forms of dengue, the most important arboviral infection of man, are associated with haemorrhagic disease and a generalised vascular leak syndrome. The importance of dengue as a cause of neurological disease is uncertain.
METHODS: During 1995, all patients with suspected CNS infections admitted to a referral hospital in southern Vietnam were investigated by culture, PCR, and antibody measurement in serum and CSF for dengue and other viruses.
FINDINGS: Of 378 patients, 16 (4.2%) were infected with dengue viruses, compared with four (1.4%) of 286 hospital controls (odds ratio [95% CI] 3.1 [1.7-5.8]). Five additional dengue positive patients with CNS abnormalities were studied subsequently. No other cause of CNS infection was identified. Seven infections were primary dengue, 13 secondary, and one was not classified. Ten patients had dengue viruses isolated or detected by PCR, and three had dengue antibody in the CSF. 12 of the 21 had no characteristic features of dengue on admission. The most frequent neurological manifestations were reduced consciousness and convulsions. Nine patients had encephalitis. No patient died, but six had neurological sequelae at discharge. Phylogenetic analysis of the four DEN-2 strains isolated mapped them with a DEN-2 strain isolated from a patient with dengue haemorrhagic fever, and with other strains previously isolated in southern Vietnam.
INTERPRETATION: In dengue endemic areas patients with encephalitis and encephalopathy should be investigated for this infection, whether or not they have other features of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10744091     DOI: 10.1016/S0140-6736(00)02036-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  165 in total

Review 1.  Dengue and Chikungunya Infections in Children : Guest Editor: Bhim S. Pandhi.

Authors:  Nitin Dhochak; Sushil K Kabra; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2018-12-04       Impact factor: 1.967

2.  Dengue encephalitis with predominant cerebellar involvement: report of eight cases with MR and CT imaging features.

Authors:  Vinay Hegde; Zarina Aziz; Sharath Kumar; Maya Bhat; Chandrajit Prasad; A K Gupta; M Netravathi; Jitender Saini
Journal:  Eur Radiol       Date:  2014-11-01       Impact factor: 5.315

Review 3.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

4.  Improved molecular detection of dengue virus serotype 1 variants.

Authors:  Jean-Marc Reynes; Sivuth Ong; Channa Mey; Chantha Ngan; Stefan Hoyer; Amadou A Sall
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

5.  The pathogenesis of spinal cord involvement in dengue virus infection.

Authors:  Jing An; De-Shan Zhou; Kazunori Kawasaki; Kotaro Yasui
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

6.  Longitudinally extensive transverse myelitis associated with dengue fever.

Authors:  Ashfaq Larik; Yi Chiong; Lynn Chooi Lee; Yee Sien Ng
Journal:  BMJ Case Rep       Date:  2012-05-11

7.  Psychiatric manifestations as the leading symptom in an expatriate with dengue fever.

Authors:  J A Blum; S Pfeifer; C F Hatz
Journal:  Infection       Date:  2010-06-22       Impact factor: 3.553

8.  [Psychiatric manifestation of a dengue-encephalopathy].

Authors:  Hans Rittmannsberger; Christian Foff; Stefan Doppler; Robert Pichler
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

9.  Dengue-associated transient muscle dysfunction: clinical, electromyography and histopathological changes.

Authors:  U K Misra; J Kalita; P K Maurya; P Kumar; S K Shankar; A Mahadevan
Journal:  Infection       Date:  2011-10-18       Impact factor: 3.553

10.  Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.

Authors:  Szu-Yuan Pu; Fei Xiao; Stanford Schor; Elena Bekerman; Fabio Zanini; Rina Barouch-Bentov; Claude M Nagamine; Shirit Einav
Journal:  Antiviral Res       Date:  2018-05-16       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.